Filana Therapeutics FLNA
NASDAQ FLNA
$0.69 0.00 (-0.50%)
As of: Oct 21, 2026 · 10:50 AM EDT

Filana Therapeutics (FLNA) Receivables (2010 - 2020)

Updated

Filana Therapeutics (FLNA) recorded Receivables of $86,000 in Q3 2020.

Analysis

Filana Therapeutics (FLNA) Receivables (2010 - 2020) Analysis & Trends

At the end of FY2010, Filana Therapeutics reported Receivables of $7.11 million.

  • The Q3 2020 figure is the highest quarterly Receivables since Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,132.46 Bn 1,101.04 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 614.45 Bn 532.98 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.76 Bn 476.87 Bn 12.70 Bn 13.82 Bn
4 Merck 367.67 Bn 322.05 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.09 Bn 262.08 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.81 Bn 235.50 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.49 Bn 191.89 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.25 Bn 165.45 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.18 Bn 116.83 Bn 10.94 Bn 12.49 Bn
10 Filana Therapeutics 33.09 Mn -337.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 86,000.00
Sep 30, 2011 231,000.00
Jun 30, 2011 908,000.00
Dec 31, 2010 7.11 Mn
API Access

Filana Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=FLNA&period=max&api_key=YOUR_API_KEY